Tempest Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2013 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Tempest Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2013 to Q2 2024.
  • Tempest Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -78.3 %, a 4.37% decline year-over-year.
  • Tempest Therapeutics, Inc. annual Return On Assets for 2023 was -82.1 %, a 42.3% decline from 2022.
  • Tempest Therapeutics, Inc. annual Return On Assets for 2022 was -57.7 %, a 47.3% decline from 2021.
  • Tempest Therapeutics, Inc. annual Return On Assets for 2021 was -39.2 %, a 12.9% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -78.3 -3.28 -4.37% Apr 1, 2024 Jun 30, 2024
Q1 2024 -79 -15 -23.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -82.1 -24.4 -42.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -90.1 -10.1 -12.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -75 +2.57 +3.31% Apr 1, 2023 Jun 30, 2023
Q1 2023 -64 +9.52 +13% Jan 1, 2023 Mar 31, 2023
Q4 2022 -57.7 +9.85 +14.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -80 -51.3 -179% Jul 1, 2022 Sep 30, 2022
Q2 2022 -77.6 -48 -162% Apr 1, 2022 Jun 30, 2022
Q1 2022 -73.5 -45 -157% Jan 1, 2022 Mar 31, 2022
Q4 2021 -67.6 -22.6 -50.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -28.6 +34.8 +54.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -29.6 +34.7 +53.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -28.5 +40 +58.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -45 +19.6 +30.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -63.4 -3.92 -6.59% Jul 1, 2020 Sep 30, 2020
Q2 2020 -64.3 -8.72 -15.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -68.5 -17.9 -35.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -64.6 -21.4 -49.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -59.5 +65.8 +52.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 -55.6 +54.4 +49.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -50.6 +63.7 +55.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -43.2 +68.8 +61.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -125 -61 -94.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -110 -45.5 -70.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -114 -57.4 -101% Jan 1, 2018 Mar 31, 2018
Q4 2017 -112 -51.7 -85.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -64.3 -7.21 -12.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -64.5 -9.39 -17% Apr 1, 2017 Jun 30, 2017
Q1 2017 -56.9 -3.08 -5.72% Jan 1, 2017 Mar 31, 2017
Q4 2016 -60.3 -13.9 -30% Oct 1, 2016 Dec 31, 2016
Q3 2016 -57.1 -5.91 -11.5% Jul 1, 2016 Sep 30, 2016
Q2 2016 -55.1 -0.07 -0.13% Apr 1, 2016 Jun 30, 2016
Q1 2016 -53.8 +4.4 +7.56% Jan 1, 2016 Mar 31, 2016
Q4 2015 -46.4 +15.2 +24.7% Oct 1, 2015 Dec 31, 2015
Q3 2015 -51.2 +3.64 +6.64% Jul 1, 2015 Sep 30, 2015
Q2 2015 -55.1 -3.71 -7.23% Apr 1, 2015 Jun 30, 2015
Q1 2015 -58.2 -7.05 -13.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -61.6 -7.84 -14.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -54.8 -10.7 -24.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 -51.3 -11.8 -29.7% Apr 1, 2014 Jun 30, 2014
Q1 2014 -51.2 -13.2 -34.7% Jan 1, 2014 Mar 31, 2014
Q4 2013 -53.7 Oct 1, 2013 Dec 31, 2013
Q3 2013 -44.2 Jul 1, 2013 Sep 30, 2013
Q2 2013 -39.6 Apr 1, 2013 Jun 30, 2013
Q1 2013 -38 Jan 1, 2013 Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.